FERI (Luxembourg) S.A.’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.5M Buy
36,330
+2,340
+7% +$600K 1.27% 20
2026
Q2
$8.55M Buy
33,990
+12,110
+55% +$2.61M 1.36% 17
2026
Q1
$4.76M Buy
21,880
+4,430
+25% +$983K 0.92% 34
2025
Q4
$3.99M Buy
+17,450
New +$3.98M 0.89% 34
2025
Q3
– Sell
-19,500
Closed -$3.62M – 81
2025
Q2
$3.62M Buy
+19,500
New +$3.62M 1.16% 28
2025
Q1
– Sell
-3,000
Closed -$533K – 93
2024
Q4
$533K Sell
3,000
-8,170
-73% -$1.5M 0.3% 86
2024
Q3
$2.21M Sell
11,170
-3,670
-25% -$685K 1.26% 13
2024
Q2
$2.55M Buy
14,840
+4,820
+48% +$798K 1.65% 13
2024
Q1
$1.82M Buy
10,020
+655
+7% +$113K 1.29% 16
2023
Q4
$1.45M Buy
+9,365
New +$1.37M 1.07% 28

Other funds holding ABBV

FERI (Luxembourg) S.A.'s ABBV Position: Q3 2026 in Review

FERI (Luxembourg) S.A. increased its AbbVie (ABBV) stake by 6.9% in Q3 2026, buying an estimated $600K and bringing the position to 36,330 shares worth $9.5M. The position accounts for 1.27% of the portfolio, ranked #20.

FERI (Luxembourg) S.A. first reported a position in ABBV in Q4 2023 and has held it in 10 quarters since. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • FERI (Luxembourg) S.A. held 36,330 shares of AbbVie worth $9.5M as of Q3 2026.
  • FERI (Luxembourg) S.A. bought 2,340 AbbVie shares in Q3 2026, an estimated $600K.
  • AbbVie made up 1.27% of FERI (Luxembourg) S.A.'s portfolio in Q3 2026, its #20 holding.
  • FERI (Luxembourg) S.A. first reported a position in AbbVie in Q4 2023 and has held it in 10 quarters since.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on FERI (Luxembourg) S.A.'s 13F filing for Q3 2026, filed 16 Nov 2026.